My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Bicycle Therapeutics Ltd (BCYC)
NASDAQ:BCYC
BCYC nasdaq
United States
Bicycle Therapeutics

Bicycle Therapeutics Stock Forecast & Price Targets

See the Price Targets and Ratings of:

Analyst Rating Consensus

Strong Buy
8Ratings
8Buy
0Hold
0Sell
Based on 8 analysts giving stock ratings to
Bicycle
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

Analyst Price Target on BCYC

Average Price Target

$67.50
▲(25.58% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Bicycle Therapeutics in the last 3 months. The average price target is $67.50 with a high forecast of $85.00 and a low forecast of $52.00. The average price target represents a 25.58% change from the last price of $53.75.
Highest Price Target$85.00
Average Price Target$67.50
Lowest Price Target$52.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AGLAgilon Health
CMPSCOMPASS Pathways
RPTXRepare Therapeutics
ZNTLZentalis Pharmaceuticals
BLUBELLUS Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis